Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 11
1946 27
1947 38
1948 54
1949 35
1950 63
1951 116
1952 97
1953 98
1954 102
1955 80
1956 81
1957 93
1958 101
1959 88
1960 90
1961 84
1962 102
1963 229
1964 324
1965 245
1966 213
1967 208
1968 250
1969 271
1970 262
1971 273
1972 316
1973 370
1974 384
1975 379
1976 385
1977 421
1978 435
1979 447
1980 430
1981 435
1982 456
1983 487
1984 572
1985 550
1986 547
1987 708
1988 729
1989 789
1990 660
1991 669
1992 745
1993 699
1994 742
1995 764
1996 744
1997 684
1998 739
1999 725
2000 658
2001 698
2002 672
2003 740
2004 766
2005 811
2006 802
2007 906
2008 896
2009 898
2010 953
2011 1096
2012 1101
2013 1110
2014 1111
2015 1174
2016 1107
2017 1107
2018 1186
2019 1216
2020 1253
2021 1426
2022 1557
2023 1478
2024 492

Text availability

Article attribute

Article type

Publication date

Search Results

42,060 results

Results by year

Filters applied: . Clear all
Page 1
IgA nephropathy.
Stamellou E, Seikrit C, Tang SCW, Boor P, Tesař V, Floege J, Barratt J, Kramann R. Stamellou E, et al. Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9. Nat Rev Dis Primers. 2023. PMID: 38036542 Review.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Lupus Nephritis Risk Factors and Biomarkers: An Update.
Renaudineau Y, Brooks W, Belliere J. Renaudineau Y, et al. Int J Mol Sci. 2023 Sep 25;24(19):14526. doi: 10.3390/ijms241914526. Int J Mol Sci. 2023. PMID: 37833974 Free PMC article. Review.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.
Zhang H, Rizk DV, Perkovic V, Maes B, Kashihara N, Rovin B, Trimarchi H, Sprangers B, Meier M, Kollins D, Papachristofi O, Milojevic J, Junge G, Nidamarthy PK, Charney A, Barratt J. Zhang H, et al. Kidney Int. 2024 Jan;105(1):189-199. doi: 10.1016/j.kint.2023.09.027. Epub 2023 Oct 31. Kidney Int. 2024. PMID: 37914086 Free article. Clinical Trial.
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.
Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. Kidney Int. 2024 Jan;105(1S):S1-S69. doi: 10.1016/j.kint.2023.09.002. Kidney Int. 2024. PMID: 38182286 Free article. No abstract available.
IgA nephropathy.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2023 Nov 30;9(1):68. doi: 10.1038/s41572-023-00483-w. Nat Rev Dis Primers. 2023. PMID: 38036576 No abstract available.
IgA Nephropathy: Beyond the Half-Century.
Shimizu Y, Tomino Y, Suzuki Y. Shimizu Y, et al. Medicina (Kaunas). 2023 Dec 27;60(1):54. doi: 10.3390/medicina60010054. Medicina (Kaunas). 2023. PMID: 38256315 Free PMC article. Review.
[IgA nephropathy].
Floege J. Floege J. Urologie. 2024 Jan;63(1):103-111. doi: 10.1007/s00120-023-02268-1. Urologie. 2024. PMID: 38170257 German.
42,060 results
You have reached the last available page of results. Please see the User Guide for more information.